MHRA refreshes the UK list of traditional herbal registrations
The Medicines and Healthcare products Regulatory Agency has updated its public list of herbal medicines holding a traditional herbal registration in the United Kingdom. The current entry points readers to a PDF attachment containing the products on the register, along with indication and quantitative composition details. For clinicians, pharmacists, and regulators, the significance lies less in any single product than in the fact that each item on the list has cleared a defined regulatory pathway for traditional herbal medicines rather than being sold in an unregulated space.
A traditional herbal registration is not a shortcut around standards. It is a formal route that allows herbal products to be marketed when they meet the criteria set out in the UK scheme, giving the public a way to distinguish registered products from loosely marketed supplements or remedies with no comparable regulatory oversight. The MHRA page links directly to the guidance for applying for a traditional herbal registration, reinforcing that the register sits within a broader legal framework rather than as a simple catalog of consumer health products.
The page itself is brief, but its function is important. Public registers act as a safety and transparency tool, especially in therapeutic areas where consumer demand is high and product quality can vary widely across the market. A physician or pharmacist reading the list is not being offered efficacy claims in the style of a randomized trial or a prescribing monograph. Instead, the message is administrative and practical: these are the herbal medicines currently holding registration status under MHRA oversight, and the published document is the authoritative record.
The update history shows periodic maintenance of the register over time, with changes recorded across multiple years. Those revisions include updates to the list itself, a switch in document format to PDF in 2024, and earlier additions of new items to the register. The chronology matters because it demonstrates that the registry is a living regulatory instrument, not a static archive. Products can be added, relisted, or documented in a different format as the agency updates its public materials.
Herbal medicines occupy an unusual position in modern therapeutics. Their appeal often rests on long-standing use, patient preference, and the perception of gentler treatment, yet those same products still require clear product identity, consistent composition, and proper regulatory classification if they are to be used responsibly. The traditional herbal registration pathway tries to balance those realities by acknowledging longstanding use while maintaining a public standard for quality and traceability. In practice, that is the part that most directly affects bedside counseling: when patients ask about a herbal product, clinicians need to know whether it sits inside a recognized regulatory structure or outside it.
One sentence captures the regulatory stakes plainly. Registered does not mean interchangeable, and it does not mean clinically proven for every claimed use.
The MHRA page points users to a PDF file containing the current list, but it does not provide clinical trial data, comparative effectiveness findings, or adverse event analyses within the page text itself. No sample sizes, populations, or therapeutic outcomes are presented here. The update is therefore best understood as a regulatory housekeeping action with practical downstream value: it keeps the public record current and allows health professionals and consumers to verify which herbal medicines have been granted traditional registration status.
For everyday clinical work, the register can be useful when patients bring in herbal products alongside prescription medicines. Herbal and conventional therapies may coexist in the same medication history, and a current official list helps identify whether a product has been reviewed through the UK’s traditional herbal medicine framework. Even without efficacy claims on the page, the existence of a formal registration can prompt more informed conversations about labeling, product identity, and safe use. It also reminds prescribers that herbal products are part of regulated medicine policy, not merely consumer wellness branding.
The update date attached to the page shows that the register remains actively maintained. The first publication date dates back to 31 December 2014, while the most recent update on the page is 2 November 2026. The page also records earlier milestones, including additions in 2016, 2017, 2018, 2019, 2022, 2024, and 2025. Those dated revisions provide a visible audit trail for a document that serves as a point of reference for regulated herbal medicine status in the UK.
The document attached to the page is 244 KB and spans 33 pages. Its length suggests a structured inventory rather than a narrative or guidance statement. For readers seeking a particular product, the PDF is the operative source. For clinicians and regulatory staff, the broader takeaway is straightforward: the MHRA continues to maintain a public register of herbal medicines under the traditional herbal registration scheme, and the current list should be used as the official reference point when questions arise about status, indication, or composition.
No new clinical claims are introduced by this update, and no therapeutic ranking is implied by appearance on the list. The document remains a regulatory index, not an endorsement of superiority, and the scope of the page is limited to the maintenance of that index. The unresolved question for practice is not whether the registry exists, but how consistently patients, pharmacists, and clinicians use it when evaluating herbal products that enter routine care.